Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): An open-label, single-arm, phase II study

A Necchi, A Anichini, D Raggi, A Briganti, S Massa, R Lucianò, M Colecchia, P Giannatempo, R Mortarini, M Bianchi, Elena Farè, F Monopoli, R Colombo, A Gallina, A Salonia, A Messina, SM Ali, R Madison, JS Ross, JH ChungR Salvioni, L Mariani, F Montorsi

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): An open-label, single-arm, phase II study'. Together they form a unique fingerprint.

Medicine & Life Sciences